Correlation Between Qiagen NV and Neuronetics
Can any of the company-specific risk be diversified away by investing in both Qiagen NV and Neuronetics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Qiagen NV and Neuronetics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Qiagen NV and Neuronetics, you can compare the effects of market volatilities on Qiagen NV and Neuronetics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Qiagen NV with a short position of Neuronetics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Qiagen NV and Neuronetics.
Diversification Opportunities for Qiagen NV and Neuronetics
-0.22 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Qiagen and Neuronetics is -0.22. Overlapping area represents the amount of risk that can be diversified away by holding Qiagen NV and Neuronetics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Neuronetics and Qiagen NV is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Qiagen NV are associated (or correlated) with Neuronetics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Neuronetics has no effect on the direction of Qiagen NV i.e., Qiagen NV and Neuronetics go up and down completely randomly.
Pair Corralation between Qiagen NV and Neuronetics
Given the investment horizon of 90 days Qiagen NV is expected to generate 4.28 times less return on investment than Neuronetics. But when comparing it to its historical volatility, Qiagen NV is 9.36 times less risky than Neuronetics. It trades about 0.12 of its potential returns per unit of risk. Neuronetics is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest 103.00 in Neuronetics on September 1, 2024 and sell it today you would lose (3.00) from holding Neuronetics or give up 2.91% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Qiagen NV vs. Neuronetics
Performance |
Timeline |
Qiagen NV |
Neuronetics |
Qiagen NV and Neuronetics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Qiagen NV and Neuronetics
The main advantage of trading using opposite Qiagen NV and Neuronetics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Qiagen NV position performs unexpectedly, Neuronetics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Neuronetics will offset losses from the drop in Neuronetics' long position.Qiagen NV vs. Neogen | Qiagen NV vs. Aclaris Therapeutics | Qiagen NV vs. IQVIA Holdings | Qiagen NV vs. Medpace Holdings |
Neuronetics vs. Burning Rock Biotech | Neuronetics vs. DarioHealth Corp | Neuronetics vs. Sera Prognostics | Neuronetics vs. Biodesix |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Other Complementary Tools
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |